Non Hodgkin Lymphoma [clinicaltrials_resource:0569ede08ad36b01b05c7b05701191f9]
clinicaltrials:NCT00062868Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. [clinicaltrials:NCT00145652]clinicaltrials:NCT00185445PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin [clinicaltrials:NCT00332202]clinicaltrials:NCT00578539Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture [clinicaltrials:NCT00808171]Methionine PET/CT Studies In Patients With Cancer [clinicaltrials:NCT00840047]Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma [clinicaltrials:NCT00907348]clinicaltrials:NCT00946023clinicaltrials:NCT00982449Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [clinicaltrials:NCT01079013]Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma [clinicaltrials:NCT01124526]Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma [clinicaltrials:NCT01482754]clinicaltrials:NCT01494103clinicaltrials:NCT01541072clinicaltrials:NCT01956084Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT02129582]clinicaltrials:NCT02339805A Phase II Prospective Study of High-dose Myeloablative Therapy, With Stem Cell Devices Support in Elderly Patients With Relapsed Aggressive Non-Hodgkin Lymphoma (NHL) or Resistant to First Line Therapy [clinicaltrials:NCT02371161]Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [clinicaltrials:NCT02507479]
condition [clinicaltrials_vocabulary:condition]
Non Hodgkin Lymphoma [clinicaltrials_resource:0569ede08ad36b01b05c7b05701191f9]
Bio2RDF identifier
0569ede08ad36b01b05c7b05701191f9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0569ede08ad36b01b05c7b05701191f9
identifier
clinicaltrials_resource:0569ede08ad36b01b05c7b05701191f9
title
Non Hodgkin Lymphoma
@en
label
Non Hodgkin Lymphoma [clinicaltrials_resource:0569ede08ad36b01b05c7b05701191f9]
@en